This article provides a comprehensive analysis of the current limitations in cancer diagnostics, exploring the foundational biological, technological, and systemic barriers that hinder accurate and timely detection.
Immunotherapy has revolutionized cancer treatment, yet patient response rates remain variable, underscoring the critical need for robust predictive biomarkers.
This article provides a comprehensive analysis for researchers and drug development professionals on the critical challenge of tumor heterogeneity in targeted cancer therapy.
Cancer stem cells (CSCs) are a therapy-resistant subpopulation that drive tumor initiation, progression, metastasis, and relapse.
This article provides a comprehensive overview of the current landscape of Chimeric Antigen Receptor (CAR)-T cell engineering and manufacturing.
This article provides a comprehensive overview of liquid biopsy technologies for cancer monitoring, tailored for researchers, scientists, and drug development professionals.
Spatial transcriptomics (ST) has emerged as a transformative technology that preserves the spatial context of gene expression within intact tissues, providing unprecedented insights into the complex architecture of the tumor...
This article provides a comprehensive overview of the transformative role of CRISPR-Cas9 technology in cancer research and therapy.
Single-cell sequencing technologies have revolutionized our understanding of tumor heterogeneity, providing unprecedented resolution to analyze genomic, transcriptomic, and epigenomic variations within individual cancer cells.
This article provides a comprehensive comparison of Digital PCR (dPCR) and Real-Time PCR (qPCR) for the detection and analysis of circulating tumor DNA (ctDNA), a critical biomarker in liquid biopsies.